These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
948 related items for PubMed ID: 18701528
1. Methicillin-resistant Staphylococcus aureus infection with intermediate sensitivity to vancomycin: a case report and literature review. Schairer J, Sankri-Tarbichi AG, Fairfax MR, Salimnia H, Guzman JA. J Intensive Care Med; 2008; 23(5):338-41. PubMed ID: 18701528 [Abstract] [Full Text] [Related]
4. Successful treatment of daptomycin-nonsusceptible methicillin-resistant Staphylococcus aureus bacteremia with the addition of rifampin to daptomycin. Ahmad NM, Rojtman AD. Ann Pharmacother; 2010 May; 44(5):918-21. PubMed ID: 20354160 [Abstract] [Full Text] [Related]
5. Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus. Fowler VG, Boucher HW, Corey GR, Abrutyn E, Karchmer AW, Rupp ME, Levine DP, Chambers HF, Tally FP, Vigliani GA, Cabell CH, Link AS, DeMeyer I, Filler SG, Zervos M, Cook P, Parsonnet J, Bernstein JM, Price CS, Forrest GN, Fätkenheuer G, Gareca M, Rehm SJ, Brodt HR, Tice A, Cosgrove SE, S. aureus Endocarditis and Bacteremia Study Group. N Engl J Med; 2006 Aug 17; 355(7):653-65. PubMed ID: 16914701 [Abstract] [Full Text] [Related]
6. Daptomycin therapy failure in an adolescent with methicillin-resistant Staphylococcus aureus bacteremia. Jacobson LM, Milstone AM, Zenilman J, Carroll KC, Arav-Boger R. Pediatr Infect Dis J; 2009 May 17; 28(5):445-7. PubMed ID: 19295462 [Abstract] [Full Text] [Related]
9. Bacteremia and infective endocarditis caused by a non-daptomycin-susceptible, vancomycin-intermediate, and methicillin-resistant Staphylococcus aureus strain in Taiwan. Huang YT, Hsiao CH, Liao CH, Lee CW, Hsueh PR. J Clin Microbiol; 2008 Mar 17; 46(3):1132-6. PubMed ID: 18199793 [Abstract] [Full Text] [Related]
10. The first pediatric case of Staphylococcus aureus with heterogenous resistant to vancomycin endocarditis in Thailand. Phongsamart W, Srifeungfung S, Tiensasitorn C, Vanprapar N, Chearskul S, Chokephaibulkit K. J Med Assoc Thai; 2005 Nov 17; 88 Suppl 8():S264-8. PubMed ID: 16856450 [Abstract] [Full Text] [Related]
11. [Lipopeptides and oxazolidinones--novel antibiotics in MRSA infection treatment]. Pangercić A, Bukovski-Simonoski S, Barsić B. Lijec Vjesn; 2010 Nov 17; 132 Suppl 1():11-3. PubMed ID: 20715711 [Abstract] [Full Text] [Related]
12. Daptomycin for the treatment of gram-positive bacteremia and infective endocarditis: a retrospective case series of 31 patients. Segreti JA, Crank CW, Finney MS. Pharmacotherapy; 2006 Mar 17; 26(3):347-52. PubMed ID: 16503714 [Abstract] [Full Text] [Related]
13. Daptomycin use after vancomycin-induced neutropenia in a patient with left-sided endocarditis. Mergenhagen KA, Pasko MT. Ann Pharmacother; 2007 Sep 17; 41(9):1531-5. PubMed ID: 17652126 [Abstract] [Full Text] [Related]
14. Methicillin-resistant Staphylococcus aureus (MRSA) mitral valve acute bacterial endocarditis (ABE) in a patient with Job's syndrome (hyperimmunoglobulin E syndrome) successfully treated with linezolid and high-dose daptomycin. Cunha BA, Krol V, Kodali V. Heart Lung; 2008 Sep 17; 37(1):72-5. PubMed ID: 18206530 [Abstract] [Full Text] [Related]
15. In vivo acquired daptomycin resistance during treatment of methicillin-resistant Staphylococcus aureus endocarditis. Dortet L, Anguel N, Fortineau N, Richard C, Nordmann P. Int J Infect Dis; 2013 Nov 17; 17(11):e1076-7. PubMed ID: 23578850 [Abstract] [Full Text] [Related]
16. New agents for Staphylococcus aureus endocarditis. Drees M, Boucher H. Curr Opin Infect Dis; 2006 Dec 17; 19(6):544-50. PubMed ID: 17075329 [Abstract] [Full Text] [Related]
17. Daptomycin treatment of Staphylococcus aureus experimental chronic osteomyelitis. Rouse MS, Piper KE, Jacobson M, Jacofsky DJ, Steckelberg JM, Patel R. J Antimicrob Chemother; 2006 Feb 17; 57(2):301-5. PubMed ID: 16361330 [Abstract] [Full Text] [Related]
18. Daptomycin therapy for invasive Gram-positive bacterial infections in children. Ardura MI, Mejías A, Katz KS, Revell P, McCracken GH, Sánchez PJ. Pediatr Infect Dis J; 2007 Dec 17; 26(12):1128-32. PubMed ID: 18043450 [Abstract] [Full Text] [Related]
19. [Consensus document for the treatment of bacteremia and endocarditis caused by methicillin-resistent Staphylococcus aureus. Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica]. Gudiol F, Aguado JM, Pascual A, Pujol M, Almirante B, Miró JM, Cercenado E, Domínguez Mde L, Soriano A, Rodríguez-Baño J, Vallés J, Palomar M, Tornos P, Bouza E, Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica. Enferm Infecc Microbiol Clin; 2009 Feb 17; 27(2):105-15. PubMed ID: 19254641 [Abstract] [Full Text] [Related]
20. [The second life of daptomycin: analysis of a successful come-back]. Decousser JW, Doucet Populaire F. Med Mal Infect; 2008 Dec 17; 38 Spec No 2():1-3. PubMed ID: 19185200 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]